Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antifibrotic effect of novel neutrophil gelatinase-associated lipocalin inhibitors in cardiac and renal disease models
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-28
DOI
10.1038/s41598-021-82279-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of lipocalin-2 in age-related macular degeneration (AMD)
- (2020) Sayan Ghosh et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Urine NGAL as a biomarker for septic AKI: a critical appraisal of clinical utility—data from the observational FINNAKI study
- (2020) Sanna Törnblom et al. Annals of Intensive Care
- Cardiovascular Consequences of Acute Kidney Injury
- (2020) Matthieu Legrand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adipose Lipocalin 2 overexpression protects against age-related decline in thermogenic function of adipose tissue and metabolic deterioration
- (2019) Jessica A. Deis et al. Molecular Metabolism
- Neutrophil Extracellular Traps Promote Inflammatory Responses in Psoriasis via Activating Epidermal TLR4/IL-36R Crosstalk
- (2019) Shuai Shao et al. Frontiers in Immunology
- Lipocalin‐2—The myth of its expression and function
- (2019) Dahui Li et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases
- (2018) Mathieu Buonafine et al. CLINICAL SCIENCE
- Aldosterone Target NGAL (Neutrophil Gelatinase–Associated Lipocalin) Is Involved in Cardiac Remodeling After Myocardial Infarction Through NFκB PathwayNovelty and Significance
- (2017) Ernesto Martínez-Martínez et al. HYPERTENSION
- Lipocalin-2 (NGAL) Attenuates Autophagy to Exacerbate Cardiac Apoptosis Induced by Myocardial Ischemia
- (2017) Hye Kyoung Sung et al. JOURNAL OF CELLULAR PHYSIOLOGY
- VSPrep: A General KNIME Workflow for the Preparation of Molecules for Virtual Screening
- (2017) José-Manuel Gally et al. Molecular Informatics
- Lipocalin-2 deficiency or blockade protects against aortic abdominal aneurysm development in mice
- (2016) Carlos Tarín et al. CARDIOVASCULAR RESEARCH
- Lipocalin 2 drives neutrophilic inflammation in alcoholic liver disease
- (2016) Verena Wieser et al. JOURNAL OF HEPATOLOGY
- Increased Lipocalin-2 Contributes to the Pathogenesis of Psoriasis by Modulating Neutrophil Chemotaxis and Cytokine Secretion
- (2016) Shuai Shao et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis
- (2016) Bilge Ören et al. JOURNAL OF PATHOLOGY
- Amelioration of cisplatin-induced acute kidney injury by recombinant neutrophil gelatinase-associated lipocalin
- (2016) Qing Ma et al. RENAL FAILURE
- ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
- (2016) Peng Guo et al. Theranostics
- Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma
- (2015) RAJ KUMAR MONGRE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Lipocalin-2 Promotes M1 Macrophages Polarization in a Mouse Cardiac Ischaemia-Reperfusion Injury Model
- (2014) L. Cheng et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Deamidated Lipocalin‐2 Induces Endothelial Dysfunction and Hypertension in Dietary Obese Mice
- (2014) Erfei Song et al. Journal of the American Heart Association
- Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes
- (2013) Joanna M. Warszawska et al. JOURNAL OF CLINICAL INVESTIGATION
- Lipocalin-2 ameliorates granulocyte functionality
- (2012) Andrea Schroll et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- NGAL (Lcn2) monomer is associated with tubulointerstitial damage in chronic kidney disease
- (2012) Thomas L. Nickolas et al. KIDNEY INTERNATIONAL
- Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm
- (2011) Priscila Ramos-Mozo et al. ATHEROSCLEROSIS
- Lipocalin 2 is essential for chronic kidney disease progression in mice and humans
- (2010) Amandine Viau et al. JOURNAL OF CLINICAL INVESTIGATION
- Iron traffics in circulation bound to a siderocalin (Ngal)–catechol complex
- (2010) Guanhu Bao et al. Nature Chemical Biology
- ANCHOR: a web server and database for analysis of protein-protein interaction binding pockets for drug discovery
- (2010) L. M. C. Meireles et al. NUCLEIC ACIDS RESEARCH
- Inhibition of Lipocalin 2 Impairs Breast Tumorigenesis and Metastasis
- (2009) X. Leng et al. CANCER RESEARCH
- Lipocalin 2 promotes breast cancer progression
- (2009) J. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search